12/18
06:01 am
bntx
3 No-Brainer Biotech Stocks to Buy With $200 Right Now [Yahoo! Finance]
Medium
Report
3 No-Brainer Biotech Stocks to Buy With $200 Right Now [Yahoo! Finance]
12/11
08:01 am
bntx
BioNTech SE (NASDAQ: BNTX) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $170.00 price target on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $170.00 price target on the stock.
12/11
06:08 am
bntx
2 Healthcare Stocks to Buy Hand Over Fist and 1 to Avoid [Yahoo! Finance]
Low
Report
2 Healthcare Stocks to Buy Hand Over Fist and 1 to Avoid [Yahoo! Finance]
12/5
10:06 pm
bntx
Duality Biologics and BioNTech Presented Positive Interim Data for Investigational B7-H3 Antibody-Drug Conjugate BNT324/DB-1311 in Advanced Solid Tumors at the ESMO Asia Congress 2024 [Yahoo! Finance]
Neutral
Report
Duality Biologics and BioNTech Presented Positive Interim Data for Investigational B7-H3 Antibody-Drug Conjugate BNT324/DB-1311 in Advanced Solid Tumors at the ESMO Asia Congress 2024 [Yahoo! Finance]
12/5
10:00 pm
bntx
Duality Biologics and BioNTech Presented Positive Interim Data for Investigational B7-H3 Antibody-Drug Conjugate BNT324/DB-1311 in Advanced Solid Tumors at the ESMO Asia Congress 2024
Low
Report
Duality Biologics and BioNTech Presented Positive Interim Data for Investigational B7-H3 Antibody-Drug Conjugate BNT324/DB-1311 in Advanced Solid Tumors at the ESMO Asia Congress 2024
12/2
03:10 pm
bntx
Why Is BioNTech SE (BNTX) Among the Best High Growth Healthcare Stocks to Invest In Now? [Yahoo! Finance]
Low
Report
Why Is BioNTech SE (BNTX) Among the Best High Growth Healthcare Stocks to Invest In Now? [Yahoo! Finance]
12/2
10:14 am
bntx
BioNTech SE (NASDAQ: BNTX) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets.
11/27
08:56 am
bntx
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $171.00 to $171.44. They now have a "buy" rating on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $171.00 to $171.44. They now have a "buy" rating on the stock.
11/26
09:43 am
bntx
BioNTech SE (NASDAQ: BNTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $124.00 to $122.00. They now have a "neutral" rating on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $124.00 to $122.00. They now have a "neutral" rating on the stock.
11/19
07:30 am
bntx
BioNTech SE (NASDAQ: BNTX) is now covered by analysts at Berenberg Bank. They set a "buy" rating and a $130.00 price target on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) is now covered by analysts at Berenberg Bank. They set a "buy" rating and a $130.00 price target on the stock.
11/19
07:30 am
bntx
BioNTech SE (NASDAQ: BNTX) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $125.00 price target on the stock, up previously from $110.00.
Low
Report
BioNTech SE (NASDAQ: BNTX) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $125.00 price target on the stock, up previously from $110.00.
11/18
08:09 am
bntx
BioNTech SE (NASDAQ: BNTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $150.00 price target on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $150.00 price target on the stock.
11/14
11:23 am
bntx
BioNTech SE (NASDAQ: BNTX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $171.00 price target on the stock.
Medium
Report
BioNTech SE (NASDAQ: BNTX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $171.00 price target on the stock.
11/13
06:45 am
bntx
BioNTech to Acquire Biotheus to Boost Oncology Strategy
Medium
Report
BioNTech to Acquire Biotheus to Boost Oncology Strategy
11/5
02:32 pm
bntx
BioNTech SE (NASDAQ: BNTX) had its price target lowered by analysts at TD Cowen from $132.00 to $122.00. They now have a "hold" rating on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its price target lowered by analysts at TD Cowen from $132.00 to $122.00. They now have a "hold" rating on the stock.
11/5
02:14 am
bntx
BioNTech SE (BNTX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Advancements ... [Yahoo! Finance]
Low
Report
BioNTech SE (BNTX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Advancements ... [Yahoo! Finance]
11/4
10:31 am
bntx
BioNTech SE (NASDAQ: BNTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $125.00 to $124.00. They now have a "neutral" rating on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $125.00 to $124.00. They now have a "neutral" rating on the stock.
11/4
06:45 am
bntx
BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update
Medium
Report
BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update
10/31
07:45 am
bntx
BioNTech to Host Innovation Series R&D Day on November 14, 2024
Low
Report
BioNTech to Host Innovation Series R&D Day on November 14, 2024
10/21
11:07 am
bntx
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at TD Cowen from $85.00 to $132.00. They now have a "hold" rating on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at TD Cowen from $85.00 to $132.00. They now have a "hold" rating on the stock.
10/21
06:45 am
bntx
BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024
Low
Report
BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024
10/7
02:12 pm
bntx
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at HSBC Holdings plc from $97.00 to $136.00. They now have a "buy" rating on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at HSBC Holdings plc from $97.00 to $136.00. They now have a "buy" rating on the stock.
10/7
08:17 am
bntx
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at HC Wainwright from $113.00 to $150.00. They now have a "buy" rating on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at HC Wainwright from $113.00 to $150.00. They now have a "buy" rating on the stock.
10/1
06:00 am
bntx
BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day
Low
Report
BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day